APA (7th ed.) Citation

D, J., CA, W., M, D., SS, W., LM, F., AP, M., . . . SS, S. (2023). Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells. Molecular and cellular biochemistry, 478(6), 1251. https://doi.org/10.1007/s11010-022-04584-0

Chicago Style (17th ed.) Citation

D, Jones, et al. "Repurposing FDA-approved Drugs as Inhibitors of Therapy-induced Invadopodia Activity in Glioblastoma Cells." Molecular and Cellular Biochemistry 478, no. 6 (2023): 1251. https://doi.org/10.1007/s11010-022-04584-0.

MLA (9th ed.) Citation

D, Jones, et al. "Repurposing FDA-approved Drugs as Inhibitors of Therapy-induced Invadopodia Activity in Glioblastoma Cells." Molecular and Cellular Biochemistry, vol. 478, no. 6, 2023, p. 1251, https://doi.org/10.1007/s11010-022-04584-0.